The role of gelsolin domain 3 in familial amyloidosis (Finnish type)
- PMID: 31243148
- PMCID: PMC6628662
- DOI: 10.1073/pnas.1902189116
The role of gelsolin domain 3 in familial amyloidosis (Finnish type)
Abstract
In the disease familial amyloidosis, Finnish type (FAF), also known as AGel amyloidosis (AGel), the mechanism by which point mutations in the calcium-regulated actin-severing protein gelsolin lead to furin cleavage is not understood in the intact protein. Here, we provide a structural and biochemical characterization of the FAF variants. X-ray crystallography structures of the FAF mutant gelsolins demonstrate that the mutations do not significantly disrupt the calcium-free conformations of gelsolin. Small-angle X-ray-scattering (SAXS) studies indicate that the FAF calcium-binding site mutants are slower to activate, whereas G167R is as efficient as the wild type. Actin-regulating studies of the gelsolins at the furin cleavage pH (6.5) show that the mutant gelsolins are functional, suggesting that they also adopt relatively normal active conformations. Deletion of gelsolin domains leads to sensitization to furin cleavage, and nanobody-binding protects against furin cleavage. These data indicate instability in the second domain of gelsolin (G2), since loss or gain of G2-stabilizing interactions impacts the efficiency of cleavage by furin. To demonstrate this principle, we engineered non-FAF mutations in G3 that disrupt the G2-G3 interface in the calcium-activated structure. These mutants led to increased furin cleavage. We carried out molecular dynamics (MD) simulations on the FAF and non-FAF mutant G2-G3 fragments of gelsolin. All mutants showed an increase in the distance between the center of masses of the 2 domains (G2 and G3). Since G3 covers the furin cleavage site on G2 in calcium-activated gelsolin, this suggests that destabilization of this interface is a critical step in cleavage.
Keywords: AGel amyloidosis; FAF; amyloid; gelsolin; structure.
Copyright © 2019 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





References
-
- Kiuru S., Matikainen E., Kupari M., Haltia M., Palo J., Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J. Neurol. Sci. 126, 40–48 (1994). - PubMed
-
- Maury C. P., Kere J., Tolvanen R., de la Chapelle A., Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13, 902–903 (1992). - PubMed
-
- Meretoja J., Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann. Clin. Res. 1, 314–324 (1969). - PubMed
-
- Taira M., et al. , Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type. Neurogenetics 13, 237–243 (2012). - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical
Research Materials